SOX9 as a Potential Biomarker of Good Prognosis in Stage II Colon Cancer

被引：0
|
作者：
Archilla, Ivan [1 ]
Cuatrecasas, Miriam [1 ]
Lahoz, Sara [2 ]
Parra, Carolina [2 ]
Mas, Alba [2 ]
Camps, Jordi [2 ]
机构：
[1] Univ Barcelona, Hosp Clin, Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
542
引用
收藏
页码：S525 / S525
页数：1
相关论文
共 50 条
  • [31] Expression of SOX9 Is Related to Prognosis in Patients with Oesophageal Squamous Cell Carcinoma
    Higo, Naotomo
    Okumura, Hiroshi
    Uchikado, Yasuto
    Omoto, Itaru
    Sasaki, Ken
    Kita, Yoshiaki
    Ryosuke, Desaki
    Noda, Masahiro
    Owaki, Tetsuhiro
    Ishigami, Sumiya
    Natsugoe, Shoji
    IN VIVO, 2018, 32 (04): : 835 - 838
  • [32] CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
    Dalerba, Piero
    Sahoo, Debashis
    Paik, Soonmyung
    Guo, Xiangqian
    Yothers, Greg
    Song, Nan
    Wilcox-Fogel, Nate
    Forgo, Erna
    Rajendran, Pradeep S.
    Miranda, Stephen P.
    Hisamori, Shigeo
    Hutchison, Jacqueline
    Kalisky, Tomer
    Qian, Dalong
    Wolmark, Norman
    Fisher, George A.
    van de Rijn, Matt
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 211 - 222
  • [33] Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis
    Zhu, Haibo
    Tang, Jie
    Tang, Mingjie
    Cai, Haikang
    DIAGNOSTIC PATHOLOGY, 2013, 8
  • [34] SOX9 Overexpression Is A Poor Prognostic Indicator in Gastric Cancer
    Luo, Wenyi
    Sun, Hongxia
    Zhang, Lei
    Ma, Junsheng
    Bassett, Roland
    Tan, Dongfeng
    MODERN PATHOLOGY, 2019, 32
  • [35] SOX9 expression and its methylation status in gastric cancer
    Sun, Minhua
    Uozaki, Hiroshi
    Hino, Rumi
    Kunita, Akiko
    Shinozaki, Aya
    Ushiku, Tetsuo
    Hibiya, Takashi
    Takeshita, Kimiko
    Isogai, Maya
    Takada, Kenzo
    Fukayama, Masashi
    VIRCHOWS ARCHIV, 2012, 460 (03) : 271 - 279
  • [36] Clinical and functional analysis of SOX9 in colorectal cancer.
    Lizarraga, Erik
    Ruiz Garcia, Erika
    Lopez-Camarillo, Cesar
    Meneses, Abelardo
    Astudillo, Horacio
    Fernandez Figueroa, Edith Araceli
    Lino-Silva, Leonardo
    Melisa Avendano-Felix, Mariana
    Parra-Niebla, Maryelv
    Bermudez-Cortes, Mercedes
    Ramos-Payan, Rosalio
    Silva-Benitez, Erik
    Geovanni Romero-Quintana, Jose
    Maribel Aguilar-Medina, Elsa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] SOX9 expression and its methylation status in gastric cancer
    Minhua Sun
    Hiroshi Uozaki
    Rumi Hino
    Akiko Kunita
    Aya Shinozaki
    Tetsuo Ushiku
    Takashi Hibiya
    Kimiko Takeshita
    Maya Isogai
    Kenzo Takada
    Masashi Fukayama
    Virchows Archiv, 2012, 460 : 271 - 279
  • [38] SOX9 Overexpression Is A Poor Prognostic Indicator in Gastric Cancer
    Luo, Wenyi
    Sun, Hongxia
    Zhang, Lei
    Ma, Junsheng
    Bassett, Roland
    Tan, Dongfeng
    LABORATORY INVESTIGATION, 2019, 99
  • [39] SOX9 regulates EGFR/ERBB signaling in pancreatic cancer
    Pinho, Andreia V.
    Grimont, Adrien
    Cowley, Mark J.
    Augereau, Cecile
    Mawson, Amanda
    Giry-Laterriere, Marc
    Van den Steen, Geraldine
    Waddell, Nicola
    Pajic, Marina
    Sempoux, Christine
    Wu, Jianmin
    Grimmond, Sean M.
    Biankin, Andrew V.
    Lemaigre, Frederic P.
    Jacquemin, Patrick
    Rooman, Ilse
    CANCER RESEARCH, 2014, 74 (19)
  • [40] Sox9 is required for prostate development and prostate cancer initiation
    Huang, Zhenhua
    Hurley, Paula J.
    Simons, Brian W.
    Marchionni, Luigi
    Berman, David M.
    Ross, Ashley E.
    Schaeffer, Edward M.
    ONCOTARGET, 2012, 3 (06) : 651 - 663
12345